SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cemtrex, Inc. engages in the provision of solutions in the technology industry. It operates through the following segments: Security, Industrial Services, and Cemtrex Corporate. The Security segment provides end-to-end security solutions to meet corporate, industrial, and governmental security challenges. The Industrial Services segment offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. The Cemtrex Corporate segment refers to the holding company of the other two segments. The company was founded on April 27, 1998 and is headquartered in Hauppauge, NY.

Cemtrex Inc.

Cemtrex Inc. ($CETX) is trending due to high volatility and significant pre-market price movement, reminiscent of recent low-float runners. The community is actively discussing the stock's multiple trading halts, potential manipulation, and whether it can sustain its momentum. Some traders are drawing comparisons to past short squeezes, while others caution against chasing the pump.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid news of acquiring Warner Bros., with the community debating the deal's impact on the company's debt and regulatory hurdles. Some believe the acquisition strengthens Netflix's content library and market position, while others worry about potential risks and competition from Paramount's counteroffer. Political factors, including potential regulatory scrutiny from the Trump administration, are also adding to the uncertainty surrounding the deal.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending as investors discuss its potential S&P 500 inclusion and the implications for its valuation. Community members are debating whether the stock is overvalued, citing the company's business model and debt, while others point to institutional ownership and potential for further gains. The stock's impressive comeback and potential for a short squeeze are also key talking points.

Treasure Global, Inc. engages in the provision of payment solutions. The firm created an online-to-offline (O2O) e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs. It operates through the ZCITY Platform and Customized Software Development Service segments. The company was founded by Kok Pin Tan on March 20, 2020 and is headquartered in New York, NY.

Treasure Global Inc

Treasure Global ($TGL) is trending due to renewed community excitement around its potential for a short squeeze, drawing comparisons to similar plays like $SMX. Bullish investors are encouraged by high borrow rates and a perceived lack of available shares for shorting, while others point to a recent revenue target update as a positive catalyst.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences ($WVE) is trending as community members discuss its recent surge potentially driven by promising data and analyst upgrades, although a new public offering announcement has sparked mixed reactions. Bullish sentiment highlights the potential of WVE's technology and pipeline, while others caution about dilution and potential pullbacks. Some traders speculate on short squeeze potential and the stock's long-term prospects in the weight loss and RNA editing space.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

PSKY is trending amid ongoing speculation about a potential acquisition of WBD, with community chatter focusing on whether Paramount will increase its offer. Some believe a deal with Warner Bros. is essential for Paramount's survival, while others suggest focusing on organic growth and existing assets like the UFC partnership. Discussions also involve potential regulatory hurdles and the possibility of a hostile takeover bid.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

TWG is trending due to a projected profit turnaround for FY25, sparking interest in its low float and potential for a significant squeeze similar to other recent runners. The community is closely watching for breakout opportunities and debating its potential to reach higher price targets. Keep an eye on this stock as traders look to capitalize on its momentum.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

GPCR is trending due to positive mid-stage trial results for their oral obesity drug, positioning it as a potential competitor in the obesity treatment market dominated by injectables; the community is buzzing about the impressive weight loss data, small molecule benefits, and potential for a takeover by a major pharmaceutical player like Novo Nordisk or JPM;  some express concerns over side effects and safety data, highlighting the competitive landscape with companies like $VKTX.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd

SUGP is trending due to its low float and potential for a short squeeze, drawing comparisons to recent explosive runs of other low-float stocks like $SMX. The community is discussing its technical setup, potential catalysts, and the possibility of a multi-day run, while also noting its volatility and prior halts.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

WBD is trending amid a potential acquisition battle, with Paramount Skydance launching a hostile bid and community members weighing the pros and cons of offers from Paramount versus Netflix. Community discussion revolves around which deal is more beneficial for shareholders, with regulatory hurdles and debt loads being key concerns. The potential deal has sparked broader debate about the future of streaming and media consolidation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CMRX don&#39;t you know Jazz Pharm wishes it had waited on buying CMRX after seeing what&#39;s going on now in the market, including biotech.

Garnett M Martin

john garscia

StockTwits Web

Chimerix Inc

 don't you know Jazz Pharm wishes it had waited on buying CMRX after seeing what's going on now in the market, including biotech.

Pablo

JAZZ might be looking for an out as you post this...

@pablo4 I’m not sure- the valuation of ONC201 is pretty insensitive to tariffs, unless there was something unque about the manufacturing of this small molecule which I wouldn’t think it’s the case. The IRA implication doesn’t touch orphan designation so that’s already assessed

StockTwits for iOS

 I’m not sure- the valuation of ONC201 is pretty insensitive to tariffs, unless there was something unque about the manufacturing of this small molecule which I wouldn’t think it’s the case. The IRA implication doesn’t touch orphan designation so that’s already assessed

Sharif S.

@Pharmacokindyn i agree JAZZ will likely come out very well anyway....but the tariffs, until today&#39;s reprieve, was rattling the bond market greatly and thus the overall market. Biotechs would not be able to negotiate deals at such a time....and surely not good deals like CMRX swung with JAZZ. CMRX wouldn&#39;t have brought 8.50 a share now, IMO....maybe later once the dust settles...but it would have either been no deal or a lower price to CMRX owners, if done in this macro climate IMO.

CMRX would have lost negotiating prowess in this environment....no fault of its own, mind you....just the whole economy backdrop that had changed quickly since the deal. They did it just in time, IMO.

StockTwits For Android 

 i agree JAZZ will likely come out very well anyway....but the tariffs, until today's reprieve, was rattling the bond market greatly and thus the overall market. Biotechs would not be able to negotiate deals at such a time....and surely not good deals like CMRX swung with JAZZ. CMRX wouldn't have brought 8.50 a share now, IMO....maybe later once the dust settles...but it would have either been no deal or a lower price to CMRX owners, if done in this macro climate IMO.

CMRX would have lost negotiating prowess in this environment....no fault of its own, mind you....just the whole economy backdrop that had changed quickly since the deal. They did it just in time, IMO.

@Pharmacokindyn I&#39;m saying that i thing JAZZ could have bought CMRX for less once fear overtook the stock market.

 I'm saying that i thing JAZZ could have bought CMRX for less once fear overtook the stock market.